The Sidney Kimmel Comprehensive Cancer Center
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Employees
- -
- Market Cap
- -
Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)
- Conditions
- GliosarcomaRecurrent Brain NeoplasmGlioblastoma
- Interventions
- Other: Laboratory Biomarker AnalysisBiological: Anti-LAG-3 Monoclonal Antibody BMS 986016Other: Pharmacological StudyBiological: Anti-CD137Biological: Anti-PD-1
- First Posted Date
- 2016-01-20
- Last Posted Date
- 2023-10-06
- Target Recruit Count
- 63
- Registration Number
- NCT02658981
- Locations
- 🇺🇸
UAB Comprehensive Cancer Center, Birmingham, Alabama, United States
🇺🇸Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio, United States
🇺🇸Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Head and Neck Cancer Treatment Related Dysphagia
- Conditions
- DysphagiaHead and Neck Cancer
- Interventions
- Other: non- head and neck self reportingOther: head neck self reportingOther: provider reporting
- Locations
- 🇺🇸
University of Washington, Seattle, Washington, United States
🇺🇸Washington University, Saint Louis, Missouri, United States
🇺🇸Lennox Hill Hospital, New York, New York, United States
Cancer DNA Detection in Blood and Urine
- Conditions
- Prostate Cancer
- Interventions
- Procedure: Urine collection and blood draw
- First Posted Date
- 2016-01-18
- Last Posted Date
- 2024-06-07
- Target Recruit Count
- 45
- Registration Number
- NCT02657863
- Locations
- 🇺🇸
Johns Hopkins SKCCC, Baltimore, Maryland, United States
Study With CY, Pembrolizumab, GVAX Pancreas Vaccine, and SBRT in Patients With Locally Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2016-01-07
- Last Posted Date
- 2023-02-28
- Target Recruit Count
- 58
- Registration Number
- NCT02648282
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore, Maryland, United States
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
- Conditions
- MedulloblastomaAstrocytoma, Grade IIIGlioblastomaAnaplastic AstrocytomaBrain Stem Neoplasms, MalignantOligodendroblastomaAnaplastic OligodendrogliomaMalignant Glioma
- Interventions
- First Posted Date
- 2015-12-31
- Last Posted Date
- 2022-06-23
- Target Recruit Count
- 16
- Registration Number
- NCT02644291
- Locations
- 🇺🇸
Johns Hopkins All Children's Hospital, Saint Petersburg, Florida, United States
🇺🇸Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
- Conditions
- Prostate CancerRecurrent Prostate CarcinomaStage IV Prostate Adenocarcinoma
- Interventions
- First Posted Date
- 2015-11-10
- Last Posted Date
- 2022-02-03
- Target Recruit Count
- 32
- Registration Number
- NCT02601014
- Locations
- 🇺🇸
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, United States
Terameprocol in Treating Patients With Recurrent High Grade Glioma
- Conditions
- High Grade Glioma (III or IV)
- Interventions
- Other: Pharmacological Study
- First Posted Date
- 2015-10-15
- Last Posted Date
- 2023-10-06
- Target Recruit Count
- 20
- Registration Number
- NCT02575794
- Locations
- 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Abrams Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸Hillman Cancer Center at University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, United States
Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2020-06-12
- Target Recruit Count
- 17
- Registration Number
- NCT02575222
- Locations
- 🇺🇸
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Markers for Predicting Risk of Breast Cancer in Women of Different Races
- Conditions
- Breast Cancer
- Interventions
- Procedure: Mastectomy
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
- Conditions
- Chronic Myelomonocytic LeukemiaChronic Lymphocytic LeukemiaChronic Myeloid LeukemiaSmall Lymphocytic LymphomaProlymphocytic LeukemiaChronic Myeloproliferative DisordersMultiple MyelomaPlasma Cell NeoplasmPlasma Cell DyscrasiaEssential Thrombocythemia
- Interventions
- Radiation: Total body irradiation
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2022-11-03
- Target Recruit Count
- 117
- Registration Number
- NCT02556931
- Locations
- 🇺🇸
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States